Community-Driven Recommendations for Developing Culturally Aligned Messaging to Improve Pre-Exposure Prophylaxis Acceptability and Uptake Among US-Based African Immigrants
AIDS Patient Care and STDs · 2025-05 · 39 (5) · 178-186
DOI: 10.1089/apc.2025.0020 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Patient Care and STDs, online erschienen am 08.05.2025. Verfasst von Gloria A Aidoo-Frimpong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Environment Health, School of Public Health and Health Professions, University of Buffalo, SUNY, Buffalo, New York, US…. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Emigrants and Immigrants, Patient Acceptance of Health Care. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
African immigrants in the United States experience increased HIV risk due to social and structural barriers such as language constraints, stigma, and cultural misconceptions. Despite this, research on effective pre-exposure prophylaxis (PrEP) messaging tailored to this population remains limited. This study examines how PrEP communication can be adapted to meet the needs of Ghanaian immigrants who represent a segment of the larger African immigrant population. Semistructured interviews were conducted, transcribed verbatim, and analyzed using NVivo 12. The analysis highlights key considerations for effective PrEP messaging, including the importance of cultural and linguistic relevance, the role of familiar and relatable messengers, and the need for clear and practical information. Participants emphasized the significance of addressing stigma and misinformation with factual, empathetic messaging and expressed a preference for ongoing community-based education about PrEP. Community leaders and health care professionals were identified as influential sources of information, capable of shaping attitudes and increasing uptake. These findings underscore the necessity of culturally tailored, community-driven approaches to PrEP messaging that bridge linguistic and cultural gaps. Integrating these insights into health communication strategies can improve awareness, acceptance, and utilization of PrEP among Ghanaian immigrants, ultimately contributing to more equitable HIV prevention efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Environment Health, School of Public Health and Health Professions, University of Buffalo, SUNY, Buffalo, New York, USA.
- Center for Interdisciplinary Research on AIDS, School of Public Health, Yale University, New Haven, Connecticut, USA.
- Department of Public Health, Calvin University, Grand Rapids, Michigan, USA.
- Behavioral, Sexual, and Global Health Lab, School of Nursing, University of Rochester, Rochester, New York, USA.
- Centre for Social Research in Health, The University of New South Wales, Sydney, Australia.
Zitieren
APA
Aidoo-Frimpong, G. A., Adekunle, T., Abu'Baare, G. R., & Adu, C. (2025). Community-Driven Recommendations for Developing Culturally Aligned Messaging to Improve Pre-Exposure Prophylaxis Acceptability and Uptake Among US-Based African Immigrants. AIDS Patient Care and STDs, 39(5), 178-186. https://doi.org/10.1089/apc.2025.0020
Vancouver
Aidoo-Frimpong GA, Adekunle T, Abu'Baare GR, Adu C. Community-Driven Recommendations for Developing Culturally Aligned Messaging to Improve Pre-Exposure Prophylaxis Acceptability and Uptake Among US-Based African Immigrants. AIDS Patient Care and STDs. 2025;39(5):178-186. doi:10.1089/apc.2025.0020
BibTeX
@article{AidooFrimpong2025,
author = {Aidoo-Frimpong, Gloria A and Adekunle, Toluwani and Abu'Baare, Gamji R and Adu, Collins},
title = {Community-Driven Recommendations for Developing Culturally Aligned Messaging to Improve Pre-Exposure Prophylaxis Acceptability and Uptake Among US-Based African Immigrants},
journal = {AIDS Patient Care and STDs},
year = {2025},
volume = {39},
number = {5},
pages = {178--186},
doi = {10.1089/apc.2025.0020}
}
EUVIMED